Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Pinatuzumab (Anti-Siglec-2 / CD22) For research use only.
Not for use in humans.

Pinatuzumab (Anti-Siglec-2 / CD22)

Synonyms: DCDT2980S

Pinatuzumab (Anti-Siglec-2 / CD22)a humanized IgG1 monoclonal antibody targeting CD22. It has potential antineoplastic activity and can be used in research of Non-Hodgkin Lymphoma. MW : 146.64 KD.

Pinatuzumab (Anti-Siglec-2 / CD22)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Pinatuzumab (Anti-Siglec-2 / CD22)a humanized IgG1 monoclonal antibody targeting CD22. It has potential antineoplastic activity and can be used in research of Non-Hodgkin Lymphoma. MW : 146.64 KD.

Product Details

CAS No. 1313706-14-7
Isotype Human IgG1
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Pinatuzumab (Anti-Siglec-2 / CD22) | Pinatuzumab (Anti-Siglec-2 / CD22) supplier | purchase Pinatuzumab (Anti-Siglec-2 / CD22) | Pinatuzumab (Anti-Siglec-2 / CD22) cost | Pinatuzumab (Anti-Siglec-2 / CD22) manufacturer | order Pinatuzumab (Anti-Siglec-2 / CD22) | Pinatuzumab (Anti-Siglec-2 / CD22) distributor